Join an ICIS committee to be a part of building up the scientific home for everything cytokine and determining the future direction of the Society.

My being involved with the society was considered a plus by NIH for my tenure and promotion. It demonstrated that I was involved with the international scientific community. 40 years later, it is still of value for new tenure tracks to demonstrate that they are not in a silo and are interacting with the broader scientific community.
Howard Young
Howard Young, PhD
Senior Investigator at the Center for Cancer Research, National Cancer Institute, NIH, Bethesda, USA Founder and Editor of -ICIS Signals+ Newsletter since 1994, 2021 ICIS Mentorship Award Winner, Past-President of the International Society for Interferon and Cytokine Research, Chair of the ICIS Membership & Communications Committee

Awards Committee

  • Judith Allen (Co-Chair, 2021-2026), University of Manchester, UK
  • Katherine Fitzgerald (Co-Chair, 2022-2024), University of Massachusetts Chan Medical School, USA
  • Snehlata Kumari (2022 – 2024), Frazer Institute, The University of Queensland, Australia
  • Hong-Gee Lee (Standing Member), PBL Assay Science, USA
  • Greg Sonnenberg (2024 – 2026), Weill Cornell Medical College, New York, USA

  • Elia Tait Wojno (2024 – 2026), University of Washington, USA  

  • Thomas A Wynn (Standing Member), Pfizer, USA
  • Hiroki Yoshida (2021 – 2026), Saga University, Japan
  • Joan Oefner, (ex-officio), ICIS Co-Managing Director, Regensburg, Germany

Nominations Committee

  • Claudia Nold (Chair, 2024 – 2026), Hudson Institute of Medical Research, Melbourne, Australia  
  • Ana Gamero (2024 – 2026), Lewis Katz School of Medicine, Temple University, Philadelphia, USA
  • Rune Hartmann (2022 – 2024), Aarhus University, Aarhus, Denmark
  • Ekaterina Koltsova (2024 – 2026), Cedars-Sinai Medical Center, Los Angeles, USA 
  • Lydia Lynch (2022 – 2024), Princeton University, Princeton, USA
  • Shruti Naik (2023 – 2025), New York University, New York, USA
  • Andreas Wack (2024 – 2026), Francis Crick Institute, London, UK
  • Stephanie Flores (ex-officio), ICIS Co-Managing Director, San Francisco, USA

Finance Committee

  • Dusan Bogunovic (Treasurer and Chair, 2019 – 2025), Icahn School of Medicine at Mount Sinai, USA
  • Kate Jeffrey (2024 – 2026), Moderna, USA 
  • Karen Mossman (2024 – 2026), McMaster University, Canada
  • Chris Hunter (2022 – 2024), University of Pennsylvania School of Veterinary Medicine, USA 
  • Stephanie Flores (ex-officio), ICIS Co-Managing Director, San Francisco, USA
  • Joan Oefner (ex-officio), ICIS Co-Managing Director, Regensburg, Germany

Early Career Researcher Committee

  • Adriana Forero, Co-Chair, (through 2026), The Ohio State University, College of Medicine, USA 
  • Juan Mendoza, Co-Chair, (through 2026) The University of Chicago, USA
  • Rami Bechara, University of Paris-Saclay, INSERM, France
  • Ruby Dawson,* South Australian immuno-GENomics Cancer Institute, The University of Adelaide, Australia
  • Kellie Ann Jurado, Perelman School of Medicine, University of Pennsylvania, USA
  • Justina Kulikauskaite* AstraZeneca, UK
  • Kevin Lee, Royal Melbourne Hospital, University of Melbourne, Australia
  • Ji Eun Oh,** Korea Advanced Institute of Science and Technology (KAIST), Korea
  • Stephanie Flores, (ex-officio), ICIS Co-Managing Director, San Francisco, USA

*ICIS Council members for Inclusion and Training, Australia
**Member, Cytokines & KAI 2024 Scientific Organizing Committee

 

Development Committee

  • David Artis (Standing ICIS Development Officer), Weill Cornell Medicine, USA
  • Eleanor Fish (Standing Member), University Health Network Dept of Cell & Molecular Biology, Canada
  • Christopher Hunter (Standing Member), University of Pennsylvania School of Veterinary Medicine, USA
  • Luke O’Neill (Standing Member), Trinity College Dublin, Ireland
  • You-Me Kim (Cytokines 2024 Korea Meeting Chair), Korea Advanced Institute of Science and Technology (KAIST), Korea
  • Michael Gale, Jr. (Cytokines 2025 Seattle Meeting Co-Chair), University of Washington, USA
  • Ram Savan (Cytokines 2025 Seattle Meeting Co-Chair), University of Washington, USA
  • Simon Jones (Cytokines 2026 Cardiff Meeting Chair), Cardiff University, Wales
  • Phil Hansbro (Cytokines 2027 Sidney Meeting Chair), Centenary UTS Centre for Inflammation, Camperdown, AU
  • Ivan Zanoni (Cytokines 2028 Boston Meeting Chair), Boston Children’s Hospital, USA
  • Joan Oefner, (ex-officio), ICIS Co-Managing Director, Regensburg, Germany
  • Stephanie Flores, (ex-officio), ICIS Co-Managing Director, San Francisco, USA

Meetings Committee

  • Brendan Jenkins (Chair 2017-2025), University of Adelaide, Australia
  • Michael Gale, Jr. (Cytokines 2025 Seattle Meeting Co-Chair), University of Washington, USA
  • Phil Hansbro (Cytokines 2027 Sidney Meeting Chair), Centenary UTS Centre for Inflammation, Camperdown, AU
  • Curt Horvath (2014-2025), Northwestern University, USA
  • Simon Jones (Cytokines 2026 Cardiff Meeting Chair), University of Cardiff, UK
  • You-Me Kim (Cytokines 2024 Korea Meeting Chair), Korea Advanced Institute of Science and Technology, Korea
  • Kellie Jurado (2023-2026), University of Pennsylvania, USA
  • Ram Savan (Cytokines 2025 Seattle Meeting Co-Chair), University of Washington, USA
  • Sandra Nicholson (2023-2026), The Walter & Eliza Hall Institute, Australia
  • Christoph Garbers (2023-2026), Institute of Clinical Biochemistry at Hannover Medical School, Germany
  • Yoshiya Tanaka (2023-2026), University of Occupational and Environmental Health, Japan
  • Ivan Zanoni (Cytokines 2028 Boston Meeting Chair), Boston Children’s Hospital, USA
  • Joan Oefner, (ex-officio), ICIS Co-Managing Director, Regensburg, Germany
  • Stephanie Flores, (ex-officio), ICIS Co-Managing Director, San Francisco, USA

Signals+ Editorial Board and Communications Committee

  • Daniella Schwartz (Co-Editor in Chief), University of Pittsburgh, USA
  • Di Yu (Co-Editor in Chief), Frazer Institute, University of Queensland, Australia
  • Saurabh Chattopadhyay, University of Toledo, USA 
  • Zhian (Anthony) Chen, Frazer Institute, University of Queensland, Australia
  • Mohamed Saad, South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia 
  • Maialen Sebastian-de la Cruz, Universidad del País Vasco / Euskal Herriko Unibertsitatea, España